Skip to content

Esketamine: all studies

Page 55 of 123: studies 541 to 550 of 1,226, newest first. Back to the esketamine overview

Research

Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray.

International Journal of Psychiatry in Clinical Practice June 1, 2024 Ludovic Samalin, Lila Mekaoui, Pierre De Maricourt et al. 3 citations

ESKALE is a French, multicentre, observational study of adults with treatment-resistant depression (TRD) treated with esketamine. This interim analysis describes baseline demographic and clinical characteristic evolution in patients included and treated from early access program to post-marketing launch. Data were collected from medical records and included patient characteristics, disease...

Effect of esketamine on the ED50 of propofol for successful insertion of ureteroscope in elderly male patients: a randomized controlled trial.

BMC Anesthesiology May 31, 2024 Xin Luo, Wen-Wen Hao, Xue Zhang et al. 7 citations

Propofol is effective and used as a kind of routine anesthetics in procedure sedative anesthesia (PSA) for ureteroscopy. However, respiratory depression and unconscious physical activity always occur during propofol-based PSA, especially in elderly patients. Esketamine has sedative and analgesic effects but without risk of cardiorespiratory depression. The purpose of this study is to...

Effects of esketamine on postoperative fatigue syndrome in patients after laparoscopic resection of gastric carcinoma: a randomized controlled trial.

BMC Anesthesiology May 24, 2024 Xinru Lin, Xiaoxue Feng, Linxiao Sun et al. 21 citations

Despite the implementation of various postoperative management strategies, the prevalence of postoperative fatigue syndrome (POFS) remains considerable among individuals undergoing laparoscopic radical gastrectomy. While the N-methyl-D-aspartic acid receptor antagonist esketamine has demonstrated efficacy in enhancing sleep quality and alleviating postoperative pain, its impact on POFS remains...

DOI: 10.1186/s12871-024-02513-w (opens in new tab) Full text (opens in new tab) Gastric carcinoma Postoperative fatigue syndrome Randomized controlled trial #esketamine-therapy ketamine +6

Dose-response study of propofol combined with two different doses of esketamine for laryngeal mask airway insertion in women undergoing hysteroscopy.

Heliyon May 15, 2024 Yan-Jun Lin, Su-Li Chen, Xiang-Li Zheng et al. 7 citations

To prospectively determine the median effective dose (ED50) of propofol for inhibiting a response to laryngeal mask airway (LMA) insertion when combined with different doses of esketamine in female patients. A total of 58 female patients (aged 20-60 years, ASAⅠ-Ⅱ) scheduled for elective hysteroscopy were enrolled and randomly divided into 2 groups, one of which was administered 0.2 mg/kg of...

DOI: 10.1016/j.heliyon.2024.e30511 (opens in new tab) Full text (opens in new tab) Esketamine Dose-response relationship Laryngeal mask airway Median effective dose +8

Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine.

Neuroscience Letters May 14, 2024 Daniele Cavaleri, Ilaria Riboldi, Cristina Crocamo et al. 13 citations

The antidepressant effects of ketamine and esketamine are well-documented. Nonetheless, most of the underlying molecular mechanisms have to be uncovered yet. In the last decade, metabolomics has emerged as a useful means to investigate the metabolic phenotype associated with depression as well as changes induced by antidepressant treatments. This mini-review aims at summarizing the main...

Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial.

Journal of the American Academy of Child & Adolescent Psychiatry May 2024 Yanling Zhou, Xiaofeng Lan, Chengyu Wang et al.

Suicide is a major cause of death in adolescents with limited treatment options. Ketamine and its enantiomers have shown rapid anti-suicidal effects in adults with major depressive disorder (MDD), but their efficacy in adolescents is unknown. We conducted an active, placebo-controlled trial to determine the safety and efficacy of intravenous esketamine in this population. A total of 54...

State-related Electroencephalography Microstate Complexity during Propofol- and Esketamine-induced Unconsciousness.

Anesthesiology May 1, 2024 Zhenhu Liang, Bo Tang, Yu Chang et al. 13 citations

Identifying the state-related "neural correlates of consciousness" for anesthetics-induced unconsciousness is challenging. Spatiotemporal complexity is a promising tool for investigating consciousness. The authors hypothesized that spatiotemporal complexity may serve as a state-related but not drug-related electroencephalography (EEG) indicator during an unconscious state induced by different...

Effect of intraoperative and/or postoperative esketamine administration on preventing postpartum depression: A systematic review and meta-analysis.

Psychiatry Research May 1, 2024 Jinping Wang, Hui Liu, Xinchuan Wei 9 citations

This systematic review and meta-analysis aimed to evaluate the impact of intraoperative and/or postoperative esketamine application on the prevention of postpartum depression (PPD). PubMed, Embase, and Web of Science were thoroughly searched for eligible randomized controlled trials (RCTs) regarding the application of esketamine for postnatal depression prevention. Nine RCTs including 1277...

DOI: 10.1016/j.psychres.2024.115890 (opens in new tab) Full text (opens in new tab) Ketamine Postnatal depression Maternal health Mental health treatment +3

Effects of a single subanesthetic dose of esketamine on postoperative subthreshold depressive symptoms in patients undergoing unilateral modified radical mastectomy: a randomised, controlled, double-blind trial.

BMC Psychiatry April 24, 2024 Huanwei Wang, Rigen Te, Jianxing Zhang et al. 15 citations

Breast cancer is the most common malignant tumor in females worldwide. During disease development, breast cancer patients suffer anxious and depressed, which may lead to worse quality of life or even higher mortality. Esketamine has been regarded as an antidepressant in breast cancer patients with mild or moderate depression. Here, we wonder whether the administration of esketamine could reduce...

Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial.

BMJ April 10, 2024 Shuo Wang, Chun-Mei Deng, Yuan Zeng et al. 64 citations

To determine whether a single low dose of esketamine administered after childbirth reduces postpartum depression in mothers with prenatal depression. Randomised, double blind, placebo controlled trial with two parallel arms. Five tertiary care hospitals in China, 19 June 2020 to 3 August 2022. 364 mothers aged ≥18 years who had at least mild prenatal depression as indicated by Edinburgh...

DOI: 10.1136/bmj-2023-078218 (opens in new tab) Full text (opens in new tab) Postpartum-depression Esketamine-therapy Maternal-mental-health Clinical-trials +1